Procter & Gamble Health Limited has informed the Exchange regarding 'Communication in respect of deduction of tax at source (TDS) on the amount ofDividend income from Procter & Gamble Health Limited'.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited has informed shareholders about the tax deduction at source (TDS) applicable on its final dividend of Rs. 45 per equity share (face value Rs. 10) recommended for FY 2024-25. The Board approved this on May 29, 2025, and it is subject to shareholder approval at the AGM on August 29, 2025. The record date for eligibility is August 22, 2025. Resident shareholders with PAN will face 10% TDS, while those without PAN face 20%; non-resident shareholders face 20% (plus surcharge and cess) or the lower DTAA rate, subject to document submission. Shareholders must submit relevant tax documents (PAN, Form 15G/15H, Form 10F for NRIs, etc.) to the RTA (KFin Technologies) by August 18, 2025 to determine the correct TDS rate.
This is a routine tax compliance communication. Shareholders should update PAN and submit the required forms by August 18, 2025 to avoid higher TDS deduction and ensure proper credit of taxes in their returns.